196 related articles for article (PubMed ID: 38198753)
1. Cardiac monoamine oxidase-A inhibition protects against catecholamine-induced ventricular arrhythmias via enhanced diastolic calcium control.
Shi Q; Malik H; Crawford RM; Streeter J; Wang J; Huo R; Shih JC; Chen B; Hall D; Abel ED; Song LS; Anderson EJ
Cardiovasc Res; 2024 May; 120(6):596-611. PubMed ID: 38198753
[TBL] [Abstract][Full Text] [Related]
2. Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors.
Valverde CA; Mazzocchi G; Di Carlo MN; Ciocci Pardo A; Salas N; Ragone MI; Felice JI; Cely-Ortiz A; Consolini AE; Portiansky E; Mosca S; Kranias EG; Wehrens XHT; Mattiazzi A
Cardiovasc Res; 2019 Mar; 115(3):556-569. PubMed ID: 30169578
[TBL] [Abstract][Full Text] [Related]
3. Exercise training prevents ventricular tachycardia in CPVT1 due to reduced CaMKII-dependent arrhythmogenic Ca2+ release.
Manotheepan R; Danielsen TK; Sadredini M; Anderson ME; Carlson CR; Lehnart SE; Sjaastad I; Stokke MK
Cardiovasc Res; 2016 Aug; 111(3):295-306. PubMed ID: 27161030
[TBL] [Abstract][Full Text] [Related]
4. Phospholamban ablation rescues the enhanced propensity to arrhythmias of mice with CaMKII-constitutive phosphorylation of RyR2 at site S2814.
Mazzocchi G; Sommese L; Palomeque J; Felice JI; Di Carlo MN; Fainstein D; Gonzalez P; Contreras P; Skapura D; McCauley MD; Lascano EC; Negroni JA; Kranias EG; Wehrens XH; Valverde CA; Mattiazzi A
J Physiol; 2016 Jun; 594(11):3005-30. PubMed ID: 26695843
[TBL] [Abstract][Full Text] [Related]
5. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.
Ai X; Curran JW; Shannon TR; Bers DM; Pogwizd SM
Circ Res; 2005 Dec; 97(12):1314-22. PubMed ID: 16269653
[TBL] [Abstract][Full Text] [Related]
6. Ca2+/calmodulin-dependent protein kinase II and protein kinase A differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology.
Fischer TH; Herting J; Tirilomis T; Renner A; Neef S; Toischer K; Ellenberger D; Förster A; Schmitto JD; Gummert J; Schöndube FA; Hasenfuss G; Maier LS; Sossalla S
Circulation; 2013 Aug; 128(9):970-81. PubMed ID: 23877259
[TBL] [Abstract][Full Text] [Related]
7. Ryanodine receptor phosphorylation by CaMKII promotes spontaneous Ca(2+) release events in a rodent model of early stage diabetes: The arrhythmogenic substrate.
Sommese L; Valverde CA; Blanco P; Castro MC; Rueda OV; Kaetzel M; Dedman J; Anderson ME; Mattiazzi A; Palomeque J
Int J Cardiol; 2016 Jan; 202():394-406. PubMed ID: 26432489
[TBL] [Abstract][Full Text] [Related]
8. Autonomous activation of CaMKII exacerbates diastolic calcium leak during beta-adrenergic stimulation in cardiomyocytes of metabolic syndrome rats.
Romero-García T; Landa-Galvan HV; Pavón N; Mercado-Morales M; Valdivia HH; Rueda A
Cell Calcium; 2020 Nov; 91():102267. PubMed ID: 32920522
[TBL] [Abstract][Full Text] [Related]
9. Ca2+/Calmodulin-dependent protein kinase II phosphorylation of ryanodine receptor does affect calcium sparks in mouse ventricular myocytes.
Guo T; Zhang T; Mestril R; Bers DM
Circ Res; 2006 Aug; 99(4):398-406. PubMed ID: 16840718
[TBL] [Abstract][Full Text] [Related]
10. NADPH oxidase 2 mediates angiotensin II-dependent cellular arrhythmias via PKA and CaMKII.
Wagner S; Dantz C; Flebbe H; Azizian A; Sag CM; Engels S; Möllencamp J; Dybkova N; Islam T; Shah AM; Maier LS
J Mol Cell Cardiol; 2014 Oct; 75():206-15. PubMed ID: 25073061
[TBL] [Abstract][Full Text] [Related]
11. The oxidation-resistant CaMKII-MM281/282VV mutation does not prevent arrhythmias in CPVT1.
Sadredini M; Manotheepan R; Lehnart SE; Anderson ME; Sjaastad I; Stokke MK
Physiol Rep; 2021 Sep; 9(18):e15030. PubMed ID: 34558218
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide-dependent activation of CaMKII increases diastolic sarcoplasmic reticulum calcium release in cardiac myocytes in response to adrenergic stimulation.
Curran J; Tang L; Roof SR; Velmurugan S; Millard A; Shonts S; Wang H; Santiago D; Ahmad U; Perryman M; Bers DM; Mohler PJ; Ziolo MT; Shannon TR
PLoS One; 2014; 9(2):e87495. PubMed ID: 24498331
[TBL] [Abstract][Full Text] [Related]
13. A Single Protein Kinase A or Calmodulin Kinase II Site Does Not Control the Cardiac Pacemaker Ca2+ Clock.
Wu Y; Valdivia HH; Wehrens XH; Anderson ME
Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003180. PubMed ID: 26857906
[TBL] [Abstract][Full Text] [Related]
14. CaMKII-dependent phosphorylation of RyR2 promotes targetable pathological RyR2 conformational shift.
Uchinoumi H; Yang Y; Oda T; Li N; Alsina KM; Puglisi JL; Chen-Izu Y; Cornea RL; Wehrens XHT; Bers DM
J Mol Cell Cardiol; 2016 Sep; 98():62-72. PubMed ID: 27318036
[TBL] [Abstract][Full Text] [Related]
15. The role of spatial organization of Ca
Belevych AE; Ho HT; Bonilla IM; Terentyeva R; Schober KE; Terentyev D; Carnes CA; Györke S
Basic Res Cardiol; 2017 Jul; 112(4):44. PubMed ID: 28612155
[TBL] [Abstract][Full Text] [Related]
16. Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.
Shan J; Xie W; Betzenhauser M; Reiken S; Chen BX; Wronska A; Marks AR
Circ Res; 2012 Aug; 111(6):708-17. PubMed ID: 22828895
[TBL] [Abstract][Full Text] [Related]
17. Acute administration of tumour necrosis factor-α induces spontaneous calcium release via the reactive oxygen species pathway in atrial myocytes.
Zuo S; Li LL; Ruan YF; Jiang L; Li X; Li SN; Wen SN; Bai R; Liu N; Du X; Dong JZ; Ma CS
Europace; 2018 Aug; 20(8):1367-1374. PubMed ID: 29045723
[TBL] [Abstract][Full Text] [Related]
18. Increased Reactive Oxygen Species-Mediated Ca
Liu X; Wang S; Guo X; Li Y; Ogurlu R; Lu F; Prondzynski M; de la Serna Buzon S; Ma Q; Zhang D; Wang G; Cotton J; Guo Y; Xiao L; Milan DJ; Xu Y; Schlame M; Bezzerides VJ; Pu WT
Circulation; 2021 May; 143(19):1894-1911. PubMed ID: 33793303
[TBL] [Abstract][Full Text] [Related]
19. Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia.
Liu N; Ruan Y; Denegri M; Bachetti T; Li Y; Colombi B; Napolitano C; Coetzee WA; Priori SG
J Mol Cell Cardiol; 2011 Jan; 50(1):214-22. PubMed ID: 20937285
[TBL] [Abstract][Full Text] [Related]
20. Ryanodine receptor phosphorylation by oxidized CaMKII contributes to the cardiotoxic effects of cardiac glycosides.
Ho HT; Liu B; Snyder JS; Lou Q; Brundage EA; Velez-Cortes F; Wang H; Ziolo MT; Anderson ME; Sen CK; Wehrens XH; Fedorov VV; Biesiadecki BJ; Hund TJ; Györke S
Cardiovasc Res; 2014 Jan; 101(1):165-74. PubMed ID: 24104877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
